In this edition:
Psylocibin & MDMA in psychiatric disorders
A 90-day intensive post-suicide programme
Empirical basis for psychodynamic psychotherapy
Ketamine for treatment-resistant depression in Australia
WEIRD mental healthcare models & socio-cultural diversity
Perspectives on ‘consumer’ vs. ‘patient’ in mental healthcare recipients
Brain changes in schizophrenia
Ethical dilemmas in violence & restraints in psychiatry
First 1000 days: developmental origins of mental health
Esketamine & quality of life in major depressive disorder
Prolactin-elevating antipsychotics & breast cancer risk
Please login below to download this issue (PDF)